BC
RCUS icon

BIT Capital’s Arcus Biosciences RCUS Stock Holding History

BIT Capital’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
+60,000
New +$1.48M 0.05% 61
2024
Q1 		– Sell
-7,000
Closed -$134K – 133
2023
Q4 		$134K Buy
+7,000
New +$112K 0.01% 82

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BIT Capital's RCUS Position: Q2 2026 in Review

BIT Capital opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 60,000 shares worth $1.85M. The stake represents 0.05% of the portfolio and ranks #61 among its holdings. This is a return to the name: BIT Capital previously reported a position in RCUS as recently as Q4 2023.

BIT Capital first reported a position in RCUS in Q4 2023 and has held it in 2 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • BIT Capital held 60,000 shares of Arcus Biosciences worth $1.85M as of Q2 2026.
  • Arcus Biosciences was a new BIT Capital position in Q2 2026.
  • Arcus Biosciences made up 0.05% of BIT Capital's portfolio in Q2 2026, its #61 holding.
  • BIT Capital first reported a position in Arcus Biosciences in Q4 2023 and has held it in 2 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.